Gene-Guided Immunotherapy Misses Mark in Recurrent/Metastatic Head and Neck Cancer
(MedPage Today) -- Gene-guided treatment selection for recurrent/metastatic head and neck squamous cell carcinoma (HNSCC) failed to improve disease control versus random treatment selection in a small preliminary clinical trial. Personalized treatment... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - March 4, 2024 Category: Hematology Source Type: news

Two Pembrolizumab Trials in Head and Neck Cancer Yield Divergent Results
(MedPage Today) -- Two first-line trials involving pembrolizumab (Keytruda)-based combinations for the treatment of recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) delivered mixed results. While first-line pembrolizumab plus... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - March 1, 2024 Category: Hematology Source Type: news

Why Is HOOKIPA Pharma Stock Trading Lower Today?
HOOKIPA Pharma Inc HOOK will focus its resources on prioritizing the clinical development of a randomized trial for its HB-200 program in human papillomavirus 16 positive (HPV16+) head and neck squamous cell carcinoma (HNSCC) and its two Gilead Science Inc GILD-partnered infectious disease cureā€¦#hookipapharmainchook #gileadscienceinc #hookipa #rocheholdingsag #rhhby #kras #gileadsciences #gilead (Source: Reuters: Health)
Source: Reuters: Health - January 29, 2024 Category: Consumer Health News Source Type: news

Lunit to showcase AI research at ESMO 2023
AI developer Lunit will present nine studies featuring the company's AI pathology technology at the upcoming European Society for Medical Oncology (ESMO) 2023 Congress in Madrid, Spain, being held October 20 to 24, 2023.The abstracts will cover a variety of areas and include the following:AI for prediction of multiple druggable mutations in non-small cell lung cancer from H&E stained imagesLunit Scope IO for distinguishing mismatch repair deficiency from mismatch repair proficiency colon cancers by analyzing features in whole slide imagesAI investigating the efficacy and safety of avelumab plus gemcitabine in leiomyosarcom...
Source: AuntMinnie.com Headlines - October 10, 2023 Category: Radiology Authors: AuntMinnie.com staff writers Tags: Industry News Source Type: news

Good Oral Health Linked to Improved Survival in Head & Neck Cancer
FRIDAY, Sept. 22, 2023 -- For patients with head and neck squamous cell carcinoma, good oral health is associated with improved survival, according to a study published online Sept. 19 in the Journal of the National Cancer Institute. Jason Tasoulas,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 22, 2023 Category: Pharmaceuticals Source Type: news

FDG-PET/CT scan reveals rare neurosarcoidosis
An FDG-PET/CT scan and thyroid biopsy changed a patient's diagnosis from termina...Read more on AuntMinnie.comRelated Reading: Are PSMA-PET tracers equal in detecting prostate cancer? PET/CT scans predict CAR-T therapy response in lymphoma patients AI outperforms clinical scores in high-risk lymphoma patients PET/CT links stress and poor outcomes in cancer patients PET/CT improves survival outcomes in patients with HNSCC (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 30, 2023 Category: Radiology Source Type: news

AI Pipeline Can Accurately Measure Sarcopenia in Head and Neck Cancer
MONDAY, Aug. 14, 2023 -- A fully automated deep learning pipeline can accurately measure sarcopenia in head and neck squamous cell carcinoma (HNSCC), which is associated with disease outcomes, according to a study published online Aug. 10 in JAMA... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 14, 2023 Category: Pharmaceuticals Source Type: news

More Intensive Imaging Follow-Up in Head, Neck Cancer? More Intensive Imaging Follow-Up in Head, Neck Cancer?
Patients with advanced head and neck squamous cell carcinoma demonstrated improved overall survival with intensive post-treatment follow-up monitoring with 18F- FDG-PET/CT vs conventional follow-up.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - August 11, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Deep learning plus CT helps guide head and neck cancer treatment
Using a deep-learning algorithm with CT imaging shows promise for diagnosin...Read more on AuntMinnie.comRelated Reading: PET/CT improves survival outcomes in patients with HNSCC Evidence supports surveillance imaging in patients with HNC CT finds secondary lung disease in head and neck cancer survivors PET/CT shows promise predicting outcomes in head, neck cancer PET radiomics tailor head/neck cancer treatment (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 10, 2023 Category: Radiology Source Type: news

PET/CT improves survival outcomes in patients with HNSCC
PET/CT scans during annual follow-up visits for patients treated for head an...Read more on AuntMinnie.comRelated Reading: Do PET/CT reports contain riddles for oncologists? PET/CT shows promise predicting outcomes in head, neck cancer PET radiomics tailor head/neck cancer treatment RT + immunotherapy = head/neck cancer treatment option CT lung screening can catch recurring head, neck cancer (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 1, 2023 Category: Radiology Source Type: news

Uncontrolled Heart Risk Factors Common in Head, Neck Squamous Cell Cancer
THURSDAY, June 29, 2023 -- The burden of suboptimally controlled cardiovascular (CV) risk factors and incident risk of stroke and myocardial infarction (MI) are considerable in patients with head and neck squamous cell carcinoma (HNSCC), according... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 29, 2023 Category: Pharmaceuticals Source Type: news

Model Can Predict Postoperative RT Delay in Head & Neck Cancer
MONDAY, April 24, 2023 -- A model incorporating individual-level factors with health literacy and community-level factors predicts postoperative radiation therapy (PORT) delay for patients with head and neck squamous cell carcinoma (HNSCC),... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 24, 2023 Category: Pharmaceuticals Source Type: news

Quitting Smoking Tied to Better Survival in Head, Neck Squamous Cell Carcinoma
TUESDAY, Feb. 14, 2023 -- Smoking cessation for>10 years is significantly associated with reduced overall mortality and head and neck squamous cell carcinoma (HNSCC)-specific mortality, according to a study published online Jan. 18 in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 14, 2023 Category: Pharmaceuticals Source Type: news

Adding Docetaxel to RT Improves Survival in Cisplatin-Ineligible Head & Neck Cancer
(MedPage Today) -- Adding docetaxel to radiation therapy (RT) improved survival outcomes in cisplatin-ineligible patients with locally advanced head and neck squamous cell carcinoma, a phase III randomized trial showed. At a median follow-up of... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - February 4, 2023 Category: Hematology Source Type: news

Pembro/Chemo Combo Fails to Improve Event-Free Survival in HNSCC Pembro/Chemo Combo Fails to Improve Event-Free Survival in HNSCC
Adding pembrolizumab to chemoradiotherapy did not significantly improve event-free survival, compared with CRT plus placebo as first-line therapy for patients with locally advanced HNSCC.MDedge News (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - September 15, 2022 Category: Radiology Tags: Hematology-Oncology News Source Type: news